loading
Schlusskurs vom Vortag:
$8.50
Offen:
$8.48
24-Stunden-Volumen:
3.75M
Relative Volume:
3.22
Marktkapitalisierung:
$1.06B
Einnahmen:
$247.00M
Nettoeinkommen (Verlust:
$-249.00M
KGV:
-2.5728
EPS:
-3.09
Netto-Cashflow:
$-267.00M
1W Leistung:
-7.77%
1M Leistung:
-11.96%
6M Leistung:
-47.94%
1J Leistung:
-47.59%
1-Tages-Spanne:
Value
$7.91
$8.64
1-Wochen-Bereich:
Value
$7.91
$8.87
52-Wochen-Spanne:
Value
$6.50
$18.98

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
Firmenname
Arcus Biosciences Inc
Name
Telefon
(510) 694-6200
Name
Adresse
3928 POINT EDEN WAY, HAYWARD, CA
Name
Mitarbeiter
674
Name
Twitter
@arcusbio
Name
Nächster Verdiensttermin
2024-12-06
Name
Neueste SEC-Einreichungen
Name
RCUS's Discussions on Twitter

Vergleichen Sie RCUS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RCUS
Arcus Biosciences Inc
7.95 1.06B 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-26 Hochstufung H.C. Wainwright Neutral → Buy
2024-10-21 Eingeleitet H.C. Wainwright Neutral
2024-10-08 Eingeleitet Wells Fargo Overweight
2022-11-18 Eingeleitet BofA Securities Neutral
2022-10-11 Eingeleitet Morgan Stanley Overweight
2021-10-15 Fortgesetzt BTIG Research Buy
2020-11-24 Eingeleitet Berenberg Buy
2020-11-23 Eingeleitet Evercore ISI Outperform
2020-04-03 Eingeleitet Cantor Fitzgerald Overweight
2020-03-04 Eingeleitet Barclays Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-09-27 Eingeleitet Mizuho Buy
2019-05-24 Fortgesetzt Citigroup Buy
2018-10-09 Eingeleitet Wedbush Outperform
2018-04-09 Eingeleitet Citigroup Buy
2018-04-09 Eingeleitet Goldman Neutral
2018-04-09 Eingeleitet Leerink Partners Outperform
Alle ansehen

Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten

pulisher
Jun 16, 2025

(RCUS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

GAMMA Investing LLC Buys 15,466 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Arcus Biosciences’ SWOT analysis: promising cancer therapy stock faces pivotal year - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

Arcus Biosciences Sees Unusually High Options Volume (NYSE:RCUS) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Arcus Biosciences Holds Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Arcus Biosciences Inc Inc. (RCUS) Price Performance: A Technical Analysis Perspective - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

Positive Signs As Multiple Insiders Buy Arcus Biosciences Stock - simplywall.st

Jun 12, 2025
pulisher
Jun 11, 2025

Arcus Biosciences Announces New Employment Inducement Grants | R - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 7,872 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on RCUS FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Arcus Biosciences Announces New Employment Inducement Grants | RCUS Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Arcus Biosciences Announces New Employment Inducement Grants - Business Wire

Jun 10, 2025
pulisher
Jun 04, 2025

When the Price of (RCUS) Talks, People Listen - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.96 Million Position in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased by Bank of America Corp DE - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Arcus Biosciences (RCUS) Unveils Promising Data for Cancer Treat - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Arcus Biosciences, Inc.Special Call - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Arcus Biosciences Presents Promising Phase 1/1b Trial Data - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Purchases 11,027 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Arcus Biosciences (RCUS) Unveils Promising Data for Cancer Treatment | RCUS Stock News - GuruFocus

Jun 01, 2025
pulisher
Jun 01, 2025

Arcus Says Initial Data From The Arc-20 Study Of Casdatifan Plus Cabozantinib Showed Nearly Half Of Patients With Metastatic Kidney Cancer Had A Confirmed Response - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Increases Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Arcus Biosciences (NYSE:RCUS) Shares Down 8.6% – Here’s What Happened - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcus Biosciences’ SWOT analysis: stock’s potential in cancer therapy market By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Purchases 9,016 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank AG Boosts Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Arcus Biosciences’ SWOT analysis: stock’s potential in cancer therapy market - Investing.com

May 28, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Has $93,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 26, 2025
pulisher
May 24, 2025

Barclays Reaffirms Their Buy Rating on Arcus Biosciences (RCUS) - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy - ACS Publications

May 23, 2025
pulisher
May 22, 2025

Recent Investment Analysts’ Ratings Changes for Arcus Biosciences (RCUS) - Defense World

May 22, 2025
pulisher
May 19, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 19, 2025

Arcus Biosciences Stock May Be The Next To Fail (NYSE:RCUS) - Seeking Alpha

May 19, 2025
pulisher
May 16, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Just Slashed This Year's Revenue Estimates By 17% - simplywall.st

May 16, 2025
pulisher
May 14, 2025

Trading (RCUS) With Integrated Risk Controls - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

Price T Rowe Associates Inc. MD Sells 6,265 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 14, 2025
pulisher
May 12, 2025

Morgan Stanley Cuts Arcus Biosciences (NYSE:RCUS) Price Target to $22.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

First Trust Advisors LP Has $264,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 11, 2025
pulisher
May 11, 2025

Cantor Fitzgerald Has Weak Forecast for RCUS FY2025 Earnings - Defense World

May 11, 2025
pulisher
May 10, 2025

HC Wainwright Predicts Weaker Earnings for Arcus Biosciences - Defense World

May 10, 2025
pulisher
May 10, 2025

Arcus Biosciences (RCUS): Morgan Stanley Lowers Price Target | R - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Wedbush Decreases Earnings Estimates for Arcus Biosciences - Defense World

May 10, 2025
pulisher
May 09, 2025

Raymond James Financial Inc. Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 09, 2025
pulisher
May 09, 2025

Morgan Stanley Lowers Price Target on Arcus Biosciences to $22 From $24, Keeps Overweight Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Goldman Sachs Adjusts Price Target for Arcus Biosciences (RCUS) - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Goldman Sachs Adjusts Price Target for Arcus Biosciences (RCUS) | RCUS Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wells Fargo Adjusts Price Target for Arcus Biosciences (RCUS) to $26 | RCUS Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Arcus Biosciences (RCUS) Receives Adjusted Price Target from Wel - GuruFocus

May 08, 2025

Finanzdaten der Arcus Biosciences Inc-Aktie (RCUS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Arcus Biosciences Inc-Aktie (RCUS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
ROSEN TERRY J
Chief Executive Officer
Feb 27 '25
Buy
10.18
19,800
201,465
2,554,160
GILEAD SCIENCES, INC.
10% Owner
Feb 18 '25
Buy
11.00
1,363,636
14,999,996
31,424,760
Goeltz II Robert C.
Chief Financial Officer
Dec 31 '24
Sale
15.00
3,594
53,910
60,138
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):